Yaozong Chen

Yaozong Chen

Auto-generated profile, based on publicly available information

Yaozong Chen

Infectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4712, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
LSLulu Sun
Lulu Sun
YZYi Zhang
Yi Zhang
JCJie Cai
Jie Cai
BRBipin Rimal
Bipin Rimal
EREdson R. Rocha
Edson R. Rocha
FGFrank Gonzalez
Frank Gonzalez
Bile salt hydrolase (BSH) in Bacteroides is considered a potential drug target for obesity-related metabolic diseases, but its involvement in colon tumorigenesis has not been explored. BSH-expressing Bacteroides is found at high abundance in the stools of colorectal cancer (CRC) patients with overweight and in the feces of a high-fat diet (HFD)-induced CRC mouse model. Colonization of B. fragilis 638R, a strain with low BSH activity, overexpressing a recombinant bsh gene from B. fragilis NCTC9343 strain, results in increased unconjugated bile acids in the colon and accelerated progression of CRC under HFD treatment. In the presence of high BSH activity, the resultant elevation of unconjugated deoxycholic acid and lithocholic acid activates the G-protein-coupled bile acid receptor, resulting in increased β-catenin-regulated chemokine (C-C motif) ligand 28 (CCL28) expression in colon tumors. Activation of the β-catenin/CCL28 axis leads to elevated intra-tumoral immunosuppressive CD25+FOXP3+ Treg cells. Blockade of the β-catenin/CCL28 axis releases the immunosuppression to enhance the intra-tumoral anti-tumor response, which decreases CRC progression under HFD treatment. Pharmacological inhibition of BSH reduces HFD-accelerated CRC progression, coincident with suppression of the β-catenin/CCL28 pathway. These findings provide insights into the pro-carcinogenetic role of Bacteroides in obesity-related CRC progression and characterize BSH as a potential target for CRC prevention and treatment.

25 January 2022 in Cell Reports
Verified
Journal Article
Open access
GBGuillaume Beaudoin-Bussières
Guillaume Beaudoin-Bussières
YCYaozong Chen
Yaozong Chen
IUIrfan Ullah
Irfan Ullah
JPJérémie Prévost
Jérémie Prévost
WTWilliam D. Tolbert
William D. Tolbert
AFAndrés Finzi
Andrés Finzi
Emerging evidence indicates that both neutralizing and Fc-mediated effector functions of antibodies contribute to protection against SARS-CoV-2. It is unclear whether Fc-effector functions alone can protect against SARS-CoV-2. Here, we isolated CV3-13, a non-neutralizing antibody, from a convalescent individual with potent Fc-mediated effector functions. The cryoelectron microscopy structure of CV3-13 in complex with the SARS-CoV-2 spike reveals that the antibody binds from a distinct angle of approach to an N-terminal domain (NTD) epitope that only partially overlaps with the NTD supersite recognized by neutralizing antibodies. CV3-13 does not alter the replication dynamics of SARS-CoV-2 in K18-hACE2 mice, but its Fc-enhanced version significantly delays virus spread, neuroinvasion, and death in prophylactic settings. Interestingly, the combination of Fc-enhanced non-neutralizing CV3-13 with Fc-compromised neutralizing CV3-25 completely protects mice from lethal SARS-CoV-2 infection. Altogether, our data demonstrate that efficient Fc-mediated effector functions can potently contribute to the in vivo efficacy of anti-SARS-CoV-2 antibodies.

15 July 2022 in Science Advances
Verified
Journal Article
Open access
YCYaozong Chen
Yaozong Chen
LSLulu Sun
Lulu Sun
IUIrfan Ullah
Irfan Ullah
GBGuillaume Beaudoin-Bussières
Guillaume Beaudoin-Bussières
SASai Priya Anand
Sai Priya Anand
MPMarzena Pazgier
Marzena Pazgier
Soluble angiotensin-converting enzyme 2 (ACE2) constitutes an attractive antiviral capable of targeting a wide range of coronaviruses using ACE2 as their receptor. Using structure-guided approaches, we developed a series of bivalent ACE2-Fcs harboring functionally and structurally validated mutations that enhance severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor binding domain recognition by up to ~12-fold and remove angiotensin enzymatic activity. The lead variant M81 potently cross-neutralized SARS-CoV-2 variants of concern (VOCs), including Omicron, at subnanomolar half-maximal inhibitory concentration and was capable of robust Fc-effector functions, including antibody-dependent cellular cytotoxicity, phagocytosis, and complement deposition. When tested in a stringent K18-hACE2 mouse model, Fc-enhanced ACE2-Fc delayed death by 3 to 5 days or effectively resolved lethal SARS-CoV-2 infection in both prophylactic and therapeutic settings via the combined effects of neutralization and Fc-effector functions. These data add to the demonstrated utility of soluble ACE2 as a valuable SARS-CoV-2 antiviral and indicate that Fc-effector functions may constitute an important component of ACE2-Fc therapeutic activity.

19 April 2022 in Minerals Engineering
Verified
Journal Article
Closed access
MLMengfei Liu
Mengfei Liu
BHBo Hu
Bo Hu
Chenyang ZhangChenyang Zhang
Chenyang Zhang
QWQiankun Wang
Qiankun Wang
ZSZhongmei Sun
Zhongmei Sun
JZJianyu Zhu
Jianyu Zhu

15 September 2014 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
BXBin Xiong
Bin Xiong
YCYin Chen
Yin Chen
YSYiwei Shu
Yiwei Shu
BSBo Shen
Bo Shen
HCHo Nam Chan
Ho Nam Chan
Hongkai WuHongkai Wu
Hongkai Wu
We prepared highly emissive and biocompatible dopamine-derived oligomers, and demonstrated their applications as novel fluorescent probes for sensitive detection of Fe3+ ions and targeted bioimaging in live cells.

21 November 2016 in Biochemistry
Verified
Journal Article
Closed access
JSJie Shi
Jie Shi
XCXinyun Cao
Xinyun Cao
YCYaozong Chen
Yaozong Chen
JCJohn E. Cronan
John E. Cronan
ZGZhihong Guo
Zhihong Guo